S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

5 best healthcare sector ETFs

Medical screening on tablet with overview of healthcare ETFs

Key Points

  • Healthcare ETFs offer investors exposure to the healthcare sector without picking individual stocks.
  • The best healthcare ETF depends on an investor's specific investment goals and risk tolerance.
  • Diversifying is essential when selecting a healthcare ETF to reduce concentration risk in any one area.
  • Compare important metrics across different healthcare ETFs to optimize returns.
  • 5 stocks we like better than BlackRock

Healthcare is one of the largest and fastest-growing sectors in the global economy, with many opportunities for investors. From breakthrough treatments to innovative technologies, healthcare companies are at the forefront of innovation and poised for growth in the years ahead. 

For those looking to invest in the healthcare sector, healthcare sector ETFs can offer a convenient and diversified way to gain exposure to this dynamic industry. These funds provide investors with a basket of healthcare-related stocks, ranging from pharmaceuticals and biotech firms to healthcare providers and medical device manufacturers. 

With so many healthcare sector ETFs available on the market, choosing the right one can take time and effort. 

So let's look closer at five of the best healthcare sector ETFs, examining their investment objectives, expense ratios, holdings and performance. From the beginner investor just starting to explore the world of healthcare investing to an experienced trader looking for new opportunities, this guide will provide the insights you need to make informed decisions about your healthcare industry ETF investments.

Overview of healthcare ETFs

A healthcare sector ETF tracks the performance of a specific index or group of healthcare-related stocks, offering investors diversified exposure to the healthcare industry. These ETFs encompass pharmaceutical and biotechnology firms, medical device manufacturers, healthcare providers and services companies.

Healthcare sector ETFs serve as essential components in diversified investment portfolios due to their unique attributes:

  • Industry diversification: They cover various sub-industries within healthcare, mitigating the impact of fluctuations in any single sector.
  • Growth potential: This sector is a long-term growth industry driven by aging populations, increasing healthcare expenditures and technological advancements.
  • Income generation: Many healthcare sector ETFs provide regular dividends, offering investors an additional income source.

The healthcare sector's importance in the global economy continues to grow due to factors like aging populations, advancements in medical technology and improved access to healthcare in developing nations.


Investing in healthcare sector ETFs presents potential advantages, such as diversification benefits, long-term growth potential and income generation. However, they also entail risks like sector-specific fluctuations, company-specific performance and regulatory changes impacting profitability.

While healthcare sector ETFs offer exposure to potential long-term growth and income, investors should carefully assess associated risks and align their investment decisions with their financial goals and risk tolerance. Thorough research and consideration are essential before making investment choices in this sector.

Best healthcare ETFs on Marketbeat infographic

The anatomy of healthcare sector ETFs

Healthcare sector ETFs encompass various sub-sectors within the expansive healthcare industry. These include pharmaceuticals, biotechnology, healthcare equipment, healthcare providers and healthcare services.

Operational mechanisms

These ETFs function by mirroring particular healthcare-related stock indices. They curate their holdings based on diverse criteria, including market capitalization, liquidity, financial stability and industry-specific attributes. Investors can purchase shares of these ETFs on exchanges, mirroring the performance of the underlying stocks.

Inclusion criteria

Stocks included in healthcare sector ETFs must meet specific criteria dictated by the indices they track. Common criteria include market capitalization thresholds, adequate liquidity for trading, financial robustness and adherence to sector-specific standards.

Historical performance

Healthcare sector ETFs have exhibited robust historical performance compared to other sectors. For instance, the Health Care Select Sector SPDR Fund NYSEARCA: XLV has demonstrated an average annual return of 11.15% over the past decade, surpassing the average return of the S&P 500, which stands at 9.54%.

Key players in healthcare sector ETFs

Healthcare sector ETFs provide investors a convenient way to gain exposure to this dynamic sector, offering diversified portfolios of healthcare-related stocks. Let's look at five top healthcare sector ETFs on the market and explore their unique features.

Health Care Select Sector SPDR Fund

Health Care Select Sector SPDR Fund NYSEARCA: XLV is one of the most widely traded and well-established healthcare sector ETFs, tracking the Health Care Select Sector Index. This broad-based ETF holds large-cap healthcare companies, including pharmaceutical giants, medical device manufacturers and healthcare providers. Its low expense ratio of 0.10% and consistent long-term performance make it a popular choice among investors seeking broad healthcare exposure.

iShares U.S. Healthcare ETF 

iShares U.S. Healthcare ETF NYSEARCA: IYH is another broad-based healthcare sector ETF, tracking the Dow Jones U.S. Health Care Index. Similar to XLV, IYH provides exposure to a diversified portfolio of large-cap healthcare companies, spanning pharmaceuticals, biotechnology, medical devices and healthcare services. With an expense ratio of 0.39%, IYH offers a slightly higher expense ratio than XLV but has demonstrated comparable historical returns.

Vanguard Health Care ETF 

Vanguard Health Care ETF NYSEARCA: VHT takes a broader approach to healthcare sector exposure, tracking the MSCI U.S. Investable Market Health Care 25/50 Index. This index includes large-, mid- and small-cap healthcare companies, providing investors with exposure to a wider range of market capitalizations. Its expense ratio of 0.10% aligns with XLV, making it a cost-effective option for broad healthcare exposure.

Invesco DWA Healthcare Momentum ETF 

Invesco DWA Healthcare Momentum ETF NYSEARCA: PTH takes a more focused approach to healthcare sector investing, tracking the Dorsey Wright Healthcare Technical Leaders Index. This index selects companies based on their relative strength, identifying those exhibiting strong price momentum. With an expense ratio of 0.60%, PTH offers the potential for higher returns but also carries higher risk due to its momentum-based strategy.

First Trust Health Care AlphaDEX Fund

First Trust Health Care AlphaDEX Fund NYSEARCA: FXH also adopts a focused approach, utilizing a proprietary stock selection methodology to identify companies with strong growth potential. The AlphaDEX system considers revenue growth, price momentum and earnings growth. With an expense ratio of 0.61%, FXH targets growth-oriented healthcare companies but carries higher risk due to its concentrated portfolio.

As the table shows, these ETFs differ in their strategies, expense ratios and historical returns. Investors should carefully consider these factors when making investment decisions.

ETF

Strategy

Expense ratio

10-year annualized return

XLV

Broad-based

0.10%

11.15%

IYH

Broad-based

0.39%

10.47%

VHT

Broad-based

0.10%

10.90%

PTH

Momentum-based

0.60%

12.21%

FXH

Growth-based

0.61%

11.78%

Investment implications

The differences among these ETFs can significantly impact an investor's decision. For instance, an investor seeking low-cost healthcare exposure may prefer XLV or VHT. Conversely, an investor with a higher risk tolerance seeking momentum-driven performance may consider PTH. However, it's crucial to acknowledge the higher risk associated with momentum-based strategies.

Furthermore, investors seeking growth-oriented healthcare companies may be drawn to FXH. Yet, they should recognize the risks associated with a concentrated portfolio. Ultimately, the choice of ETF depends on an investor's individual risk tolerance, investment objectives and time horizon.

The healthcare sector is continuously transforming, driven by many factors that influence its trajectory and shape the future of medicine. Understanding these trends and their potential impact is crucial if you consider investing in healthcare sector ETFs.

Revolutionizing healthcare delivery

Technological advancements stand at the forefront of revolutionizing healthcare delivery. Artificial intelligence (AI) transforms diagnostics, treatment planning and drug discovery. Machine learning algorithms can analyze patient data to identify patterns and predict risk factors, enabling personalized medicine and early disease detection.

Robotic surgery is gaining traction, offering minimally invasive procedures with enhanced precision and reduced recovery times. 3D printing technology is paving the way for customized prosthetics, implants, and medical devices tailored to individual patients' needs.

Ensuring safety, quality and affordability

Governments worldwide are increasingly regulating the healthcare industry to ensure patient safety, quality of care and affordability. These regulations encompass drug approvals, medical device standards, healthcare data privacy and pricing transparency. 

Stringent regulatory oversight can impact the development and approval timelines of new drugs and devices, affecting the competitive landscape within the healthcare sector. However, these regulations also foster trust and confidence among patients, ensuring they receive safe and effective treatments.

Highlighting global preparedness and collaboration

The emergence of new infectious diseases and the ongoing COVID-19 pandemic have emphasized the importance of global health preparedness and collaboration. Public health agencies and research institutions worldwide are working together to develop vaccines, treatments and diagnostic tools to combat emerging threats.

Global health crises can strain healthcare systems and disrupt supply chains, impacting the performance of healthcare sector ETFs. However, they also drive investment in pandemic preparedness and innovation, leading to advancements in infectious disease management and surveillance.

These trends are bound to influence the performance of healthcare sector ETFs in various ways. Technological advancements could propel innovative healthcare companies to the forefront, potentially boosting the value of ETFs invested in these sectors.

Regulatory changes, while ensuring patient safety, could impact timelines and costs associated with drug development and device approvals, affecting the financial performance of certain companies. Global health crises can disrupt supply chains and strain healthcare systems, potentially impacting the overall performance of healthcare sector ETFs.

As the healthcare sector evolves, several potential future trends include:

  • The aging population: The increasing number of older adults globally should drive demand for healthcare services, particularly in geriatric care and chronic disease management.
  • Rising healthcare costs: The continuous rise is a significant concern for governments and individuals. Healthcare sector ETFs with exposure to companies focused on cost-optimization and value-based care could benefit from this trend.
  • The convergence of technology and healthcare: Technology integration into healthcare is expected to accelerate, leading to the development of innovative diagnostic tools, treatment modalities and telemedicine solutions. Healthcare sector ETFs invested in companies at the forefront of this convergence could see potential growth.

Investors should consider these emerging trends carefully when investing in healthcare sector ETFs. Aligning investment choices with long-term trends can potentially enhance returns and align you with the future direction of the healthcare sector.

Five best healthcare ETFs

Our five best healthcare sector ETFs have been selected based on various factors, including their performance history, expense ratios and portfolio composition (the types of stocks in the portfolio). Each ETF offers slightly different exposure to the healthcare sector, so it's essential to understand their differences before making an investment decision. From broad-based healthcare ETFs to more focused options, these five healthcare ETFs represent some of the best options for investors seeking exposure to the healthcare sector. 

Health Care Select Sector SPDR Fund 

Health Care Select Sector SPDR Fund NYSEARCA: XLV is a popular and widely traded ETF, providing broad exposure to the healthcare sector. The ETF's inception date was December 16, 1998, and State Street Global Advisors manages the ETF. With over $35 billion in assets under management, XLV is one of the largest healthcare ETFs.

The expense ratio for XLV is 0.10%, which is relatively low for a healthcare ETF. The ETF has a dividend yield of around 1.5%, which may appeal to income-oriented investors. The average daily volume for XLV is relatively high, with over 9 million shares trading hands on a typical day.

XLV's top holdings include some of the largest and most well-known healthcare companies, such as Johnson & Johnson NYSE: JNJ, Pfizer Inc. NYSE: PFE and UnitedHealth Group Inc. NYSE: UNH. The ETF also provides exposure to various healthcare sub-industries, including pharmaceuticals, biotech and healthcare equipment.

XLV's risk profile is generally moderate, including exposure to large and mid-cap healthcare companies. The investment objective of XLV is to provide investors with investment results that correspond to the performance of the Health Care Select Sector Index, a subset of the S&P 500. This ETF typically appeals to investors seeking broad exposure to the healthcare sector.

iShares U.S. Healthcare ETF 

The iShares U.S. Healthcare ETF NYSEARCA: IYH is a popular choice for investors seeking exposure to diversified companies in the healthcare sector. This fund has a long-term track record of solid performance and is an option for long-term investment investors. 

The expense ratio for IYH is 0.39%, which is lower than the average expense ratio for funds with similar holdings. The ETF has a dividend yield of around 1.13%, which can provide investors with additional income.

The average daily volume for IYH is over 46,000 shares, indicating a moderate level of liquidity. Additionally, the ETF has over $3 billion in assets under management, which is a testament to its popularity among investors.

BlackRock, one of the world's largest asset managers, launched IYH in 2000. The fund's top holdings include healthcare giants such as Johnson & Johnson, Pfizer and Merck & Co NYSE: MRK. The ETF offers exposure to a similar set of companies as XLV but with a slightly different weighting methodology.

From a risk perspective, IYH is considered a moderately conservative investment. The fund has a diversified portfolio of healthcare companies, which helps to mitigate the risks associated with investing in any single company. The investment objective of IYH is to track the performance of the Dow Jones U.S. Health Care Index represents the healthcare sector of the U.S. equity market.

iShares U.S. Healthcare ETF is an attractive option for investors looking for a slightly different healthcare sector investing approach than XLV. With its strong long-term performance, low expense ratio and high liquidity, IYH may be suitable for those seeking a long-term investment in the healthcare sector.

Vanguard Health Care ETF

Vanguard Health Care ETF NYSEARCA: VHT is an ETF that tracks the MSCI U.S. Investable Market Health Care 25/50 Index and provides exposure to a broad range of large-, mid- and small-cap healthcare stocks in the U.S. market. This ETF has a low expense ratio of 0.10%, making it a cost-effective option for investors seeking to invest in the healthcare sector.

VHT has provided robust performance over the years, making it an attractive option for investors with a long-term investment horizon. The fund offers a long-term track record of solid performance, though it's worth noting that past performance does not guarantee future results.

The ETF also has a solid dividend yield, which makes it an attractive option for income-seeking investors. Additionally, this ETF's average daily trading volume is relatively high, making it a liquid investment option for investors.

The fund started on January 26, 2004. Vanguard manages VHT and is one of the largest investment management companies in the world, which adds to the fund's credibility. The top holdings in VHT include some of the most well-known companies in the healthcare industry, such as Johnson & Johnson, Pfizer Inc. and UnitedHealth Group Inc. The sector allocation is well-diversified, with pharmaceuticals, biotech and healthcare equipment industries represented as the top three sectors.

In terms of risk profile, VHT is considered to be a moderate-risk investment due to the inherent volatility of the healthcare sector. However, the broad-based exposure and diversified portfolio of the fund can help mitigate some risks associated with investing in individual healthcare companies.

The investment objective of VHT is to provide investors with exposure to the healthcare sector in the U.S. market and to achieve returns that closely correspond to the performance of the MSCI U.S. Investable Market Health Care 25/50 Index. Overall, VHT is an attractive option for investors seeking broad-based exposure to the healthcare sector with low expense ratios and solid historical performance.

Invesco DWA Healthcare Momentum ETF

Invesco DWA Healthcare Momentum ETF NYSEARCA: PTH is an exchange-traded fund that seeks to track the performance of the Dorsey Wright Healthcare Technical Leaders Index. This index identifies and captures price momentum in the healthcare sector by selecting companies with strong relative strength characteristics. The fund is excellent for investors seeking exposure to healthcare stocks exhibiting strong price momentum.

The expense ratio for PTH is higher than some other healthcare ETFs, but it offers the potential for higher returns due to its focus on momentum investing. The fund has a low dividend yield, but its emphasis on capital appreciation rather than income generation may suit investors with a longer-term investment horizon.

The ETF's average daily volume and assets under management are relatively low compared to larger healthcare ETFs. However, this may be due to its focus on a specific investment strategy. The fund was launched in 2006, making it a relatively mature option for healthcare sector investing.

The issuer of PTH is Invesco, a global investment management firm with a long history of managing ETFs and other investment products. The fund's top holdings include large- and mid-cap healthcare companies, with a particular focus on biotechnology and pharmaceuticals.

Investors should know that the focus on momentum investing may result in higher volatility and potentially more significant risk than other healthcare ETFs. As with any investment, it is essential to carefully consider the risks and potential rewards before deciding.

First Trust Health Care AlphaDEX Fund

The First Trust Health Care AlphaDEX Fund NYSEARCA: FXH is an ETF focusing on the healthcare sector and seeking exposure to companies with strong growth potential. The ETF uses a proprietary stock selection methodology called the AlphaDEX system, which identifies companies based on growth factors such as revenue growth, price momentum and earnings growth. FXH's holdings are reconstituted and rebalanced quarterly to maintain its focus on growth-oriented companies.

FXH's expense ratio is slightly higher than some of its peers in the healthcare sector, but it may be worth it for investors seeking exposure to companies with solid growth potential. The ETF's dividend yield is modest and may not be a primary consideration for investors looking for growth stocks. It has a moderate daily trading volume, indicating it is a reasonably liquid investment.

The ETF has existed since May 2007 and has grown substantially, with over $1.5 billion of assets under management. The issuer of FXH is First Trust Advisors, a reputable and established provider of investment products.

FXH's top holdings are primarily large-cap healthcare companies, with pharmaceutical and biotech firms making up a significant portion of the portfolio. This ETF may be suitable for investors who are comfortable with the potential risks associated with investing in individual stocks within the healthcare sector, as it is more concentrated than some of its peers.

Keys to investing in healthcare ETFs

Investing in healthcare ETFs can be an excellent way for investors to gain exposure to the healthcare sector without picking individual stocks. However, as with any investment, investors should consider certain key factors when selecting a healthcare ETF. Let's take a moment to discuss some of the critical considerations for investing in healthcare ETFs, including diversification, expense ratios, liquidity and risk management. By understanding these factors, investors can make more informed decisions about which healthcare ETFs may suit their investment goals and risk tolerance. 

Diversification

One key factor to consider when investing in healthcare ETFs is diversification, which can help reduce the risk of concentration in one area. When selecting a healthcare ETF, investors should look for those that offer exposure to a diverse range of healthcare sub-industries and companies. This can help ensure the ETF is adequately concentrated in one area, such as pharmaceuticals or biotech. Additionally, investors should consider the geographic diversity of the ETF, as exposure to international markets can also help to diversify the portfolio further. 

One tip for investing in healthcare ETFs is avoiding overexposure to any sub-industry or company by spreading investments across multiple healthcare ETFs or incorporating other sectors into a well-diversified portfolio. You can use MarketBeat's overview of stock sectors to learn more about each sector and how to diversify your portfolio further. If you want to dig into a particular ETF's diversification, a great place to get started is MarketBeat's "full holdings" page, which is provided for each ETF. You can find this button on the left side of each profile directly under the ETF's top holdings list.   

Expense ratios

Expense ratios are essential when investing in healthcare ETFs, as they can significantly impact an investor's returns. Investors should compare the expense ratios of different healthcare ETFs to identify cost-effective options. Lower expense ratios are generally preferred to help minimize costs and increase returns. 

One tip for investors when evaluating expense ratios is to look beyond the management fee and consider any other fees or expenses associated with the ETF, such as trading costs or bid-ask spreads. To dig into expense ratios for a particular ETF, review that ETF's MarketBeat profile. Pay attention to the breakdown of expenses halfway down the page; it even provides other valuable metrics regarding expense ratios. 

It's also worth noting that some healthcare ETFs may have higher expense ratios due to their unique investment strategies, such as active management or proprietary stock selection methodologies. In such cases, investors should evaluate whether the potential benefits of these strategies outweigh the higher costs.

Liquidity

When investing in healthcare ETFs, liquidity is an essential factor to consider. Investors should look for ETFs with a high average daily volume and significant assets under management, indicating sufficient liquidity to trade the ETF without experiencing substantial price fluctuations. 

Additionally, investors should consider the daily range spread, the difference between the day's highest price for an ETF share and the day's lowest price. A narrower daily spread indicates that there is more liquidity in the market for the ETF. It is generally advisable to refrain from trading ETFs with low liquidity, as this can result in difficulty in buying or selling shares at desired prices or, even worse, significant price fluctuations. 

MarketBeat has helped simplify this process by providing this information in the header of every listing, making it much easier to see if a particular asset aligns with your specific goals. 

Risk management

When evaluating the risk profile of a healthcare ETF, investors should consider the historical volatility and exposure to market fluctuations to ensure that it aligns with their investment objectives and risk tolerance. It's important to remember that higher-risk ETFs may offer the potential for greater returns, but they can also lead to more significant losses in down markets. 

To manage risk, investors may consider diversifying their healthcare ETF holdings, investing in ETFs with lower volatility or investing in defensive healthcare subsectors. Additionally, investors can monitor the ETF's performance over time to ensure it aligns with their investment goals and risk tolerance. Once you have found the ETF that fits best into your portfolio, you might also want to review the ETF's price targets and analyst ratings for that ETF. 

Risks and challenges of healthcare sector ETF investing 

While healthcare sector ETFs offer investors exposure to a dynamic and potentially lucrative industry, it is crucial to recognize the inherent risks and challenges associated with these investments. Before you decide to invest in healthcare ETFs, carefully evaluate the following factors to make informed investment decisions:

A delicate balance

The healthcare industry is linked to a complex regulatory framework, and shifts in these regulations can significantly influence healthcare companies' profitability. Regulatory changes encompass a broad spectrum, from stringent drug approval processes to pricing controls and reimbursement policies. 

For instance, if a government institutes stricter drug approval guidelines, pharmaceutical companies may face extended timelines and increased costs to bring their products to market. It could negatively impact the financial performance of those companies and, consequently, affect the value of healthcare sector ETFs invested in them.

A hurdle-filled race

The path from a promising drug discovery to FDA approval is often fraught with uncertainties and high failure rates. Clinical trials, the pivotal step in assessing a drug's safety and efficacy, can be lengthy, expensive and prone to setbacks. A single failed trial or even a delay in the approval process can dramatically impact a pharmaceutical company's stock price, sending ripples through healthcare sector ETFs that hold those stocks.

A ripple effect on healthcare

The healthcare sector is not immune to the ebb and flow of global geopolitical dynamics. International health crises, political instability and trade disputes can disrupt supply chains, hinder research collaborations and ultimately impact the demand for healthcare products and services. These events can have far-reaching consequences for healthcare sector ETFs, particularly those exposed to international companies or markets.

Healthcare sector ETFs are inherently exposed to the overall performance of the healthcare sector. Economic downturns can lead to reduced healthcare spending, while technological advancements or regulatory changes can disrupt existing business models and favor certain sub-sectors over others. For instance, the rise of telemedicine may benefit companies providing virtual healthcare services while potentially posing challenges to traditional brick-and-mortar healthcare providers.

The individual pieces of the puzzle

Healthcare sector ETFs typically hold a basket of healthcare-related stocks, and the performance of the ETF is directly linked to the performance of these individual companies. Any negative news or events related to a specific company can impact the overall value of the ETF. For example, a product recall, a safety concern, or a legal battle involving a major pharmaceutical company could send shockwaves through the entire healthcare sector, affecting the entire portfolio of a healthcare sector ETF.

To effectively mitigate these risks and enhance the sustainability of healthcare sector ETF investments, consider implementing the following strategies:

Spread the risk

Diversify across multiple healthcare sector ETFs to reduce exposure to any single company or sub-sector. This diversification principle is akin to not putting all your eggs in one basket. By spreading your investment across various ETFs, you can lessen the impact of any negative performance from a particular company or sub-sector.

Embrace the cyclical nature of healthcare

Adopt a long-term investment horizon to weather short-term volatility and potentially benefit from the long-term growth prospects of the healthcare sector. Healthcare, like many industries, experiences cyclical fluctuations. Taking a long-term perspective, you can focus on the sector's overall growth trajectory rather than getting caught up in short-term market swings.

Understand the underlying holdings

Conduct thorough research on the underlying holdings of the ETFs to understand their investment philosophy, risk profile and exposure to specific sub-sectors or companies. This due diligence process is crucial for making informed investment decisions. By understanding the composition of your ETF portfolio, you can assess your risk tolerance and align your investment choices with your financial goals.

Maintain equilibrium in your portfolio

Periodically rebalance your portfolio to maintain desired asset allocation and reduce exposure to underperforming components. Rebalancing involves periodically reassessing the proportion of your investments allocated to each ETF in your portfolio to ensure they align with your target asset allocation. This practice helps maintain diversification and prevents overexposure to any specific ETF.

Delegate decision-making

Consider actively managed healthcare sector mutual funds for investors seeking more active risk management. Actively managed funds employ the expertise of professional fund managers who research and select investments based on their assessment of market conditions and individual company prospects. This hands-off approach can be appealing to investors who prefer not to engage in in-depth research and stock selection.

Ride the waves of healthcare innovation

Despite the inherent risks and challenges, the healthcare sector is poised for long-term growth driven by several fundamental factors:

  • Aging population: The increasing number of older adults globally should drive significant demand for healthcare services, particularly geriatric care and chronic disease management. As the population ages, the need for medical interventions, specialized care and long-term care facilities should rise, creating opportunities for healthcare companies catering to this demographic.
  • Technological advancements: The rapid pace of technological innovation in healthcare is revolutionizing treatment modalities, diagnostic tools and patient care. Advancements in artificial intelligence, robotics, genomics and personalized medicine are transforming the industry, leading to more effective treatments, early disease detection and tailored healthcare solutions.
  • Rising healthcare expenditures: While rising healthcare costs pose challenges, they also indicate the increasing societal demand for quality healthcare services. As economies develop and living standards improve, healthcare expenditures should continue growing, fueling the demand for innovative healthcare products and services.
  • Expanding access to healthcare: Expanding access to healthcare services in developing countries and underserved communities represents a vast untapped market potential. As healthcare infrastructure and insurance coverage expand, more people will access necessary medical care, driving growth in the healthcare sector.
  • Evolving healthcare needs: The changing nature of diseases and the emergence of new health threats constantly reshape the healthcare landscape. Healthcare companies at the forefront of addressing emerging health challenges, developing preventive measures and combating infectious diseases are well-positioned for long-term growth.

Healthcare sector ETFs offer investors exposure to a diverse and dynamic industry with long-term growth potential. While careful consideration of the inherent risks and challenges is essential, the underlying drivers of healthcare demand and innovation suggest that healthcare sector ETFs could be a valuable component of a well-diversified investment portfolio.

By understanding the regulatory environment, drug approval process, geopolitical factors and sector-specific and company-specific risks, investors can make informed decisions about allocating their investments in healthcare sector ETFs. Diversification, a long-term investment horizon, thorough research, periodic rebalancing and the potential benefits of active management can all contribute to achieving sustainable growth and success in healthcare sector ETF investing.

Strategies for investing in healthcare sector ETFs

Healthcare sector ETFs offer investors exposure to a diverse and dynamic industry with long-term growth potential. However, as with any investment, careful consideration of various factors is crucial for making informed decisions and achieving sustainable success. Let’s dig into the intricacies of healthcare sector ETF investing, exploring strategies aligned with risk tolerance, investment goals and time horizons.

Assess your risk tolerance

Before embarking on any investment journey, it is essential to gauge your risk tolerance and the level of risk you are comfortable accepting in pursuit of potential returns. Healthcare sector ETFs, like any equity-based investment, carry inherent risks associated with market fluctuations, regulatory changes and company-specific events.

If you are an investor with a conservative risk profile, opting for broad-based healthcare sector ETFs that track large-cap companies can provide diversification and reduce exposure to the volatility of individual companies. Additionally, considering ETFs with lower expense ratios can optimize returns over time.

A combination of broad-based and more focused healthcare sector ETFs may be suitable for investors with a moderate risk tolerance. This diversified approach exposes the overall sector's growth while incorporating targeted bets on specific sub-sectors or themes within the healthcare industry.

High-risk tolerance investors may consider incorporating actively managed healthcare sector ETFs into their portfolios. These ETFs employ the expertise of professional fund managers who actively select and adjust holdings based on their market outlook and company assessments. This hands-on approach can lead to higher returns but also carries increased risk.

Align investment strategies with investment goals

Your investment goals are pivotal in shaping your healthcare sector ETF investment strategy. If your goal is long-term wealth accumulation, investing in healthcare sector ETFs aligned with long-term growth trends can be a prudent approach.

For instance, consider ETFs that focus on companies developing innovative medical technologies, addressing unmet medical needs, or catering to the growing elderly population. These long-term trends are likely to shape the future of healthcare, potentially driving the value of ETFs invested in these areas.

If your investment goal is to generate regular income, healthcare sector ETFs with exposure to dividend-paying companies can be attractive. Dividend-paying healthcare companies often have established market positions and generate consistent cash flows, making them potential sources of stable income.

Remember, your investment goals should tailor to your circumstances, including age, financial situation and risk tolerance. Consulting a financial advisor can provide personalized guidance and help align your investment strategies with your long-term objectives.

Consider your investment time horizon

Your investment time horizon, the period you plan to hold your investments significantly influences your healthcare sector ETF investment strategy. If you have a short-term investment horizon, you may prioritize ETFs focusing on companies likely to benefit from near-term catalysts, such as regulatory approvals, clinical trial results or product launches.

However, if you have a long-term investment horizon, you can adopt a more strategic approach, investing in ETFs that capitalize on long-term trends shaping the healthcare sector. Such ETFs may have higher exposure to innovative companies or those addressing evolving healthcare needs, potentially leading to substantial growth over time.

Case studies of successful investment strategies

Several case studies exemplify successful healthcare sector ETF investment strategies:

Healthcare sector ETFs offer investors a compelling opportunity to gain exposure to a dynamic and evolving industry with long-term growth potential. By carefully considering your risk tolerance, investment goals, and time horizon, you can tailor your investment strategies to align with your financial objectives and potentially achieve success in the healthcare sector's ETF realm. Remember, diversification, thorough research and a long-term investment perspective are crucial for navigating the intricacies of healthcare sector ETF investing.

Consider investing in healthcare sector ETFs 

Investing in healthcare sector ETFs can offer investors the opportunity to gain exposure to this growing and dynamic industry while minimizing risk and costs. Investors can decide which healthcare ETFs align with their investment objectives and risk tolerance by carefully considering factors such as diversification, expense ratios, liquidity and risk management.

While these ETFs offer different approaches and investment styles, they all provide exposure to the healthcare sector and have a track record of solid performance. As with any investment, investors must do their due diligence before making investment decisions.

FAQs

Now that we have discussed the five best healthcare sector ETFs and some key factors to consider when investing in healthcare ETFs, you may have some questions about the topic. 

In this FAQ section, we will address some common questions that investors may have about healthcare ETFs, including their benefits, risks and how to choose the right one for your investment portfolio.

What is the best healthcare ETF? 

There is no single "best" healthcare ETF, as different investors may have different investment objectives and risk tolerances. However, investors can consider various factors such as diversification, expense ratios, liquidity and risk management when selecting a healthcare ETF that suits their needs.

What is the biggest healthcare ETF? 

As of the writing of this article, the most significant ETF healthcare stock in terms of assets under management is the Health Care Select Sector SPDR Fund NYSEARCA: XLV that we covered in this article. This ETF tracks the Health Care Select Sector Index, which includes large-cap healthcare companies.

What are the top five healthcare ETFs to buy?

The top five healthcare ETFs to buy may vary depending on an investor's specific needs and preferences. However, some popular options among investors include the Health Care Select Sector SPDR Fund (XLV), iShares U.S. Healthcare ETF (IYH), Vanguard Health Care ETF (VHT), Invesco DWA Healthcare Momentum ETF NYSEARCA: PTH and First Trust Health Care AlphaDEX Fund NYSEARCA: FXH

It's essential to conduct thorough research and analysis before making any investment decisions. One way to help you choose a suitable ETF is to compare healthcare ETF stocks on MarketBeat

Should you invest $1,000 in BlackRock right now?

Before you consider BlackRock, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BlackRock wasn't on the list.

While BlackRock currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
BlackRock (BLK)
4.6709 of 5 stars
$747.08-0.9%2.73%18.99Moderate Buy$845.42
First Trust Health Care AlphaDEX Fund (FXH)N/A$101.59-0.5%0.22%19.12N/AN/A
Health Care Select Sector SPDR Fund (XLV)N/A$138.430.0%1.44%23.49N/AN/A
Invesco Dorsey Wright Healthcare Momentum ETF (PTH)N/A$39.53-2.4%1.13%9.70N/AN/A
iShares U.S. Healthcare ETF (IYH)N/A$58.040.0%5.38%4.91N/AN/A
Johnson & Johnson (JNJ)
4.8712 of 5 stars
$145.74+0.7%3.27%9.09Hold$175.86
MSCI (MSCI)
4.767 of 5 stars
$505.42-1.3%1.27%35.10Hold$581.57
Pfizer (PFE)
4.9926 of 5 stars
$25.39-0.1%6.62%70.51Hold$36.88
State Street (STT)
4.9729 of 5 stars
$73.04+0.3%3.78%13.68Hold$84.04
UnitedHealth Group (UNH)
4.9582 of 5 stars
$493.16+3.0%1.52%30.14Moderate Buy$569.68
Vanguard Health Care ETF (VHT)N/A$252.83-0.1%1.31%23.10N/AN/A
Compare These Stocks  Add These Stocks to My Watchlist 

Jeffrey Neal Johnson

About Jeffrey Neal Johnson

  • jeffrey.neal.johnson@gmail.com

Contributing Author

Retail and Technology Stocks

Experience

Jeffrey Neal Johnson has been a contributing writer for MarketBeat since 2023.

Areas of Expertise

Technology, cryptocurrency, biotechnology, defense sector, automotive industry, hospitality sector

Education

Associate of Arts in Business Development

Past Experience

Strategic business development and ventures 


Featured Articles and Offers

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

JNJ shares hit a low, trading near $145 at under 14X earnings. With a high dividend yield, it's poised for a rebound.

Search Headlines: